Limits...
Dengue Vaccines: A Perspective from the Point of View of Intellectual Property.

da Veiga CP, da Veiga CR, Del Corso JM, da Silva WV - Int J Environ Res Public Health (2015)

Bottom Line: The results show that 93% of patents were granted since 2000, the majority belonging to the United States and Europe, although the share of patents from developing countries has increased.Finally, in this study, the main holders showed high knowledge absorption and generated capabilities.Therefore, this issue suggests that to overcome the difficulty of translational R & D it is necessary to stimulate the generation of knowledge and relevant scientific research, to enable the productive sector to have the capacity to absorb knowledge, to turn it into innovation, and to articulate partnerships and collaboration.

View Article: PubMed Central - PubMed

Affiliation: Pontifical Catholic University of Paraná, PUCPR, Rua Imaculada Conceição, 1155 Prado Velho, 80215-901 Curitiba, PR, Brazil. claudimar.veiga@gmail.com.

ABSTRACT
Dengue is a serious infectious disease and a growing public health problem in many tropical and sub-tropical countries. To control this neglected tropical disease (NTD), vaccines are likely to be the most cost-effective solution. This study analyzed dengue vaccines from both a historical and longitudinal perspective by using patent data, evaluating the geographic and time coverage of innovations, the primary patent holders, the network of cooperation and partnership for vaccine research and development (R & D), the flow of knowledge and the technological domain involved. This study can be seen as an example of the use of patent information to inform policy discussions, strategic research planning, and technology transfer. The results show that 93% of patents were granted since 2000, the majority belonging to the United States and Europe, although the share of patents from developing countries has increased. Unlike another NTDs, there is great participation of private companies in R & D of dengue vaccines and partnerships and collaboration between public and private companies. Finally, in this study, the main holders showed high knowledge absorption and generated capabilities. Therefore, this issue suggests that to overcome the difficulty of translational R & D it is necessary to stimulate the generation of knowledge and relevant scientific research, to enable the productive sector to have the capacity to absorb knowledge, to turn it into innovation, and to articulate partnerships and collaboration.

No MeSH data available.


Related in: MedlinePlus

Type, acquisition and treatment of the data under study.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4555291&req=5

ijerph-12-09454-f001: Type, acquisition and treatment of the data under study.

Mentions: This study used data from patent families published between 1970 and 2014 that were retrieved from Questel Orbit® (Sao Paulo, Brazil) a patent database with integrated Web based patent analysis software. Unlike other patent databases, Questel Orbit® allows patent analysis visualizations, designed to give answers to key business questions. Data were selected using the International Patent Classification (IPC) code A61K-039, which refers to medicinal preparations that contain antigens and antibodies. The search was refined using the keywords “dengue” and “vaccin+” in the title and abstract in order to differentiate patent documents related to another vaccines and diagnostic methods. The command line was ((DENGUE)/TI/AB AND (VACCIN+)/TI/AB) AND (A61K-039)/IPC. All patent data from the database were primary analyzed to establish temporal distribution, geographical distribution and co-ownership distribution (see Figure 1). In a second moment, patent data were analyzed about co-owner relationships, citation relationships and technological domains (see Figure 1). The search results were correlated with other data sources to provide insights not obtained by other studies.


Dengue Vaccines: A Perspective from the Point of View of Intellectual Property.

da Veiga CP, da Veiga CR, Del Corso JM, da Silva WV - Int J Environ Res Public Health (2015)

Type, acquisition and treatment of the data under study.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4555291&req=5

ijerph-12-09454-f001: Type, acquisition and treatment of the data under study.
Mentions: This study used data from patent families published between 1970 and 2014 that were retrieved from Questel Orbit® (Sao Paulo, Brazil) a patent database with integrated Web based patent analysis software. Unlike other patent databases, Questel Orbit® allows patent analysis visualizations, designed to give answers to key business questions. Data were selected using the International Patent Classification (IPC) code A61K-039, which refers to medicinal preparations that contain antigens and antibodies. The search was refined using the keywords “dengue” and “vaccin+” in the title and abstract in order to differentiate patent documents related to another vaccines and diagnostic methods. The command line was ((DENGUE)/TI/AB AND (VACCIN+)/TI/AB) AND (A61K-039)/IPC. All patent data from the database were primary analyzed to establish temporal distribution, geographical distribution and co-ownership distribution (see Figure 1). In a second moment, patent data were analyzed about co-owner relationships, citation relationships and technological domains (see Figure 1). The search results were correlated with other data sources to provide insights not obtained by other studies.

Bottom Line: The results show that 93% of patents were granted since 2000, the majority belonging to the United States and Europe, although the share of patents from developing countries has increased.Finally, in this study, the main holders showed high knowledge absorption and generated capabilities.Therefore, this issue suggests that to overcome the difficulty of translational R & D it is necessary to stimulate the generation of knowledge and relevant scientific research, to enable the productive sector to have the capacity to absorb knowledge, to turn it into innovation, and to articulate partnerships and collaboration.

View Article: PubMed Central - PubMed

Affiliation: Pontifical Catholic University of Paraná, PUCPR, Rua Imaculada Conceição, 1155 Prado Velho, 80215-901 Curitiba, PR, Brazil. claudimar.veiga@gmail.com.

ABSTRACT
Dengue is a serious infectious disease and a growing public health problem in many tropical and sub-tropical countries. To control this neglected tropical disease (NTD), vaccines are likely to be the most cost-effective solution. This study analyzed dengue vaccines from both a historical and longitudinal perspective by using patent data, evaluating the geographic and time coverage of innovations, the primary patent holders, the network of cooperation and partnership for vaccine research and development (R & D), the flow of knowledge and the technological domain involved. This study can be seen as an example of the use of patent information to inform policy discussions, strategic research planning, and technology transfer. The results show that 93% of patents were granted since 2000, the majority belonging to the United States and Europe, although the share of patents from developing countries has increased. Unlike another NTDs, there is great participation of private companies in R & D of dengue vaccines and partnerships and collaboration between public and private companies. Finally, in this study, the main holders showed high knowledge absorption and generated capabilities. Therefore, this issue suggests that to overcome the difficulty of translational R & D it is necessary to stimulate the generation of knowledge and relevant scientific research, to enable the productive sector to have the capacity to absorb knowledge, to turn it into innovation, and to articulate partnerships and collaboration.

No MeSH data available.


Related in: MedlinePlus